Daily News Podcast

Updated anthrax vaccine recommendations

Publish date: July 2, 2018

 

The advisory committee on Immunization Practices voted to approve recommendations for the use of Anthrax Vaccine Adsorbed (AVA) in post-exposure prophylaxis (PEP) in the event of a wide-area release of Bacillus anthracis spores. Also today, the FDA approves topical anticholinergic for primary axillary hyperhidrosis, a shortage of ob.gyns. looms, and more Americans missed care in 2017 as a result of cost.

Listen to the MDedge Daily News for today’s top news.

Recommended Reading

Impact of varicella vaccination on herpes zoster is not what was expected
MDedge Infectious Disease
Galectin-3: A post-MI prognostic biomarker for our times
MDedge Infectious Disease
Herpesvirus infections may have a pathogenic link to Alzheimer’s disease
MDedge Infectious Disease
Herpesvirus infections may have a pathogenic link to Alzheimer’s disease
MDedge Infectious Disease
Patients going without as insulin prices skyrocket
MDedge Infectious Disease
FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome
MDedge Infectious Disease
Opioids do more harm than good for musculoskeletal pain
MDedge Infectious Disease
Addiction: Veterans with pain, opioid use disorder
MDedge Infectious Disease
Anthrax vaccine recommendations updated in the event of a wide-area release
MDedge Infectious Disease
Medicare beneficiaries are dying differently
MDedge Infectious Disease